Nkarta, Inc.
Public company- Headquarters
- SOUTH SAN FRANCISCO, California
- Ticker
- NKTX
- CIK
- 0001787400
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| Mar 26, 2025 | 52 | 52 |
| Mar 26, 2025 | 1 | 53 |
Leadership
No executive changes on record.
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
layoffs from Mar 31, 2025
WARN noticeWARN notice: CA
Nkarta, Inc. filed a WARN notice with the California WARN list on Mar 26, 2025 covering 1 worker. The layoffs take effect on Mar 31, 2025.
Source: California WARN list, filed Mar 26, 2025Site: CA
Workers affected: 1
layoffs from Mar 31, 2025
WARN noticeWARN notice: CA
Nkarta, Inc. filed a WARN notice with the California WARN list on Mar 26, 2025 covering 52 workers. The layoffs take effect on Mar 31, 2025.
Source: California WARN list, filed Mar 26, 2025Site: CA
Workers affected: 52
Last verified Nov 8, 2026